Skip to main content
SLSBio(Specialty Lab Solution Bio) Co., Ltd logo

SLSBio(Specialty Lab Solution Bio) Co., Ltd — Investor Relations & Filings

Ticker · 246250 ISIN · KR7246250005 KO Professional, scientific and technical activities
Open in API
Filings indexed 261 across all filing types
Latest filing 2021-04-01 Regulatory Filings
Country KR South Korea
Listing KO 246250

About SLSBio(Specialty Lab Solution Bio) Co., Ltd

http://www.slabs.co.kr/

SLSBio (Specialty Lab Solution Bio) Co., Ltd. is a company specializing in laboratory solutions and support services for the pharmaceutical and biotechnology sectors. Its primary offerings include pharmaceutical quality control testing, clinical trial sample analysis, bioequivalence studies, drug stability testing, and new drug development support. In addition to its service portfolio, the company develops and manufactures diagnostic technologies, reagents, and other biological agents, supporting various stages of the drug development and commercialization lifecycle.

Recent filings

Filing Released Lang Actions
기타주요경영사항(자율공시)
Regulatory Filings Classification · 95% confidence The document is a 'voluntary disclosure' (자율공시) regarding the designation of the company as a veterinary drug testing institution by the Ministry of Agriculture, Food and Rural Affairs. It does not fit into specific financial reporting categories like 10-K, IR, or ER, nor is it a simple report publication announcement. As it is a regulatory announcement of a significant business development, it falls under the general regulatory filing category.
2021-04-01 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of a General Meeting of Shareholders (정기주주총회 결과). It details the approval of financial statements, dividend resolutions, and other agenda items (such as board compensation and articles of incorporation changes). This falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2021-03-30 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a short regulatory filing titled '감사보고서 제출' (Submission of Audit Report) which provides a summary of the audit opinion and key financial figures for the fiscal year. It is a standard regulatory disclosure in the Korean market (DART system) announcing the completion and submission of the audit report. Since it is a short summary announcement of the audit results rather than the full, multi-page audit report document itself, it falls under the category of Audit Report / Information (AR). FY 2020
2021-03-22 Korean
사업보고서 (2020.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the fiscal year 2020, filed by SLSBio (주식회사 에스엘에스바이오) to the Financial Supervisory Service (FSS) and Korea Exchange. It contains comprehensive company information, business overview, financial history, and governance details. In the context of Korean regulatory filings, the 'Business Report' (사업보고서) is the equivalent of the US 10-K annual report, as it is the primary annual disclosure document containing audited financial statements and management analysis. FY 2020
2021-03-22 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집 결의) issued by SLS Bio. It outlines the date, location, and agenda items (such as approval of financial statements, director compensation, and articles of incorporation changes) for the upcoming meeting. This type of document is a standard proxy solicitation or information statement provided to shareholders to inform them of the meeting and the matters to be voted upon.
2021-03-15 Korean
주주총회집중일개최사유신고
AGM Information Classification · 95% confidence The document is a formal notification filed by SLS Bio regarding the scheduling of their Annual General Meeting (AGM) on a 'concentrated date' (a date where many companies hold their AGMs). It explains the reason for choosing this date despite regulatory efforts to disperse meeting dates. Since this is a regulatory disclosure regarding meeting logistics and not the meeting materials themselves, the proxy statement, or the voting results, it falls under the general regulatory filing category.
2021-03-15 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.